Effect of esomeprazole on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader, in healthy participants
Lana Tran, Naihan Chen, Jennifer A. Winton, Kyle T. Matschke, Smita P. Goodman, Kimberly C. Lee, Yuanyuan Zhang, Weiwei Tan · 2026
Read Effect of esomeprazole on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera oestrogen receptor degrader, in healthy participants by Lana Tran, Naihan Chen, Jennifer A. Winton, Kyle T. Matschke, Smita P. Goodman, Kimberly C. Lee, Yuanyuan Zhang, Weiwei Tan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13619030.txt.
Description
Lana Tran and seven colleagues report a 2026 Phase 1 drug-interaction study asking whether an acid suppressor changes how the body handles vepdegestrant. The drug is an experimental estrogen receptor degrader being developed for advanced breast cancer. Because the drug dissolves by pH, stomach-acid reduction could cut its absorption. Twelve volunteers took one dose alone in one period, then, in a second period, one dose after five days of esomeprazole, with blood sampled for a week.
Exposure fell with the acid suppressor on board: exposure ran at eighty-four percent of the drug-alone value, and peak concentration at seventy-four percent. A similar dip appeared for the drug's epimer form. All twelve treatment-emergent adverse events across seven participants were mild, and the dose was well tolerated. The authors conclude that combining the two only mildly lowers vepdegestrant levels, information prescribers need when patients take common reflux medicines.
Catalog record
| CREATOR | Lana Tran, Naihan Chen, Jennifer A. Winton, Kyle T. Matschke, Smita P. Goodman, Kimberly C. Lee, Yuanyuan Zhang, Weiwei Tan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26892 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |